Adipose tissue dysfunction in obesity and lipodystrophy

Clinical Cornerstone

Volumn 8, Issue SUPPL. 4, 2006, Pages

  Garg, Abhimanyu ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; ANDROGEN; ESTROGEN; FATTY ACID; FIBRIC ACID DERIVATIVE; GLYCEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 6; LEPTIN; METFORMIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; ORAL ANTIDIABETIC AGENT; RECOMBINANT LEPTIN; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VISFATIN;

ACUTE PANCREATITIS; AEROBIC EXERCISE; AROMATIZATION; ARTICLE; AUTOCRINE EFFECT; BRAIN; BROWN ADIPOSE TISSUE; CYTOKINE RELEASE; DIABETES MELLITUS; DIET RESTRICTION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DYSLIPIDEMIA; ENDOCRINE FUNCTION; ENERGY EXPENDITURE; FATTY LIVER; GENETIC RISK; HOMEOSTASIS; HORMONE ACTION; HORMONE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPODYSTROPHY; LIVER; METABOLIC SYNDROME X; MYOPATHY; OBESITY; OVULATION; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN SECRETION; REGULATORY MECHANISM; RISK FACTOR; SIDE EFFECT; SKELETAL MUSCLE; STARVATION; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; CYTOKINES; HUMANS; LIPODYSTROPHY; OBESITY; PROGNOSIS; RISK FACTORS; TRIGLYCERIDES;

EID: 33845921647     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1098-3597(06)80039-6     Document Type: Article

References (33)

1. Abate N., and Garg A. Heterogeneity in adipose tissue metabolism: Causes, implications and management of regional adiposity. Prog Lipid Res. 34 (1995) 53-70
2. Eckel R.H. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med. 320 (1989) 1060-1068
3. Scow R.O., and Blanchette-Mackie E.J. Why fatty acids flow in cell membranes. Prog Lipid Res. 24 (1985) 197-241
4. Abumrad N., Harmon C., and Ibrahimi A. Membrane transport of long-chain fatty acids: Evidence for a facilitated process. J Lipid Res. 39 (1998) 2309-2318
5. Leung D.W. The structure and functions of human lysophosphafidic acid acyltransferases. Front Biosci. 6 (2001) d944-d953
6. Bell R.M., and Coleman R.A. Enzymes of glycerolipid synthesis in eukaryotes. Annu Rev Biochem. 49 (1980) 459-487
7. Hammond L.E., Gallagher P.A., Wang S., et al. Mitochondrial glycerol-3-phosphate acyluansferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition. Mol Cell Biol. 22 (2002) 8204-8214
8. Cases S., Smith S.J., Zheng Y.W., et al. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci USA 95 (1998) 13018-13023
9. Cases S., Stone S.J., Zhou P., et al. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J Biol Chem. 276 (2001) 38870-38876
10. Garg A. Acquired and genetic lipodystrophies. N Engl J Med. 350 (2004) 1220-1234
11. Agarwal A.K., Barnes R.I., and Garg A. Genetic basis of congenital generalized lipodystrophy. Int J Obes Relat Metal, Disord. 28 (2004) 336-339
12. Hales C.N., Luzio J.P., and Siddle K. Hormonal control of adiposetissue lipolysis. Biochem Soc Symp. 43 (1978) 97-135
13. Bjorntorp P., and Ostman J. Human adipose tissue dynamics and regulation. Adv Metal, Disord. 5 (1971) 277-327
14. Haque W.A., and Garg A. Adipocyte biology and adipocytokines. Clin Lab Med. 24 (2004) 217-234
15. discussion 213-214. Simpson E.R., Zhao Y., Agarwal V.R., et al. Aromatase expression in health and disease. Recent Prog Horm Res. 52 (1997) 185-213
16. Misso M.L., Jang C., Adams J., et al. Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause 12 (2005) 210-215
17. Abate N., Garg A., Peshock R.M., et al. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 45 (1996) 1684-1693
18. Abate N., Garg A., Peshock R.M., et al. Relationship of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest. 96 (1995) 88-98
19. Garg A., and Misra A. Lipodystrophies: Rare disorders causing metabolic syndrome. Endocrinol Metab. Clin N Am. 33 (2004) 305-331
20. Haque W.A., Shimomura I., Matsuzawa Y., and Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab. 87 (2002) 2395-2398
21. Oral E.A., Simha V., Ruiz E., et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 346 (2002) 570-578
22. Simha V., Szczepaniak L.S., Wagner Al., et al. Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy. Diabetes Care 26 (2003) 30-35
23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
24. Garg A. Lipodystrophies. Am J Med. 108 (2000) 143-152
25. Garg A., and Misra A. Hepatic steatosis, insulin resistance, and adipose tissue disorders. J Clin Endocrinol Metab. 87 (2002) 3019-3022
26. Garg A., and Misra A. Lipodystrophies and diabetes. In: DeFronzo R.A., Ferrannini E., Keen H., et al. (Eds). International Textbook of Diabetes Mellitus. 3rd ed. (2004), Wiley, New York, NY 655-672
27. Agarwal A.K., and Garg A. Congenital generalized lipodystrophy: Significance of triglyceride biosynthetic pathways. Trends Endocrinol Metab. 14 (2003) 214-221
28. Agarwal A.K., and Garg A. Seipin: A mysterious protein. Trends Mol Med. 10 (2004) 440-444
29. Chen D., Misra A., and Garg A. Lipodystrophy in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab. 87 (2002) 4845-4856
30. Garg A., and Grundy S.M. Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. JAMA 264 (1990) 723-726
31. Haque W.A., Vuitch F., and Garg A. Post-mortem findings in familial partial lipodystrophy, Dunnigan variety. Diabetes Med. 19 (2002) 1022-1025
32. Simha V., Szczepaniak L.S., Wagner A., et al. Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy. Diabetes Care 26 (2003) 30-35
33. Petersen K.F., Oral E.A., Dufour S., et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109 (2002) 1345-1350